Haptoglobin polymorphism and complications in established essential arterial hypertension

Area of Science:

• Genetics and Cardiovascular Disease
• Pharmacogenomics
• Hypertension Research

Background:

• Haptoglobin (Hp) polymorphism has been linked to salt sensitivity and blood pressure in normotensive individuals.
• Understanding Hp's role in established hypertension is crucial for personalized treatment strategies.

Purpose of the Study:

• To investigate haptoglobin phenotypes in relation to hypertension indices.
• To assess the severity of complications and arterial disease occurrence in hypertensive patients with different Hp phenotypes.
• To determine the impact of Hp polymorphism on therapeutic needs in established arterial hypertension.

Main Methods:

• Starch-gel electrophoresis was used to determine haptoglobin (Hp) polymorphism.
• Study included 302 Caucasian patients with essential arterial hypertension treated for at least one year.
• Logistic regression analysis was employed to identify factors influencing therapeutic needs.

Main Results:

• Haptoglobin allele frequencies (Hp 1 and Hp 2) were comparable between hypertensives and controls.
• The Hp 2-2 phenotype was identified as a significant contributor to increased therapeutic needs in hypertension.
• Coronary artery disease, Hp 2-2, BMI, and left ventricular hypertrophy were key factors determining treatment requirements.

Conclusions:

• Hypertensives with the Hp 2-2 phenotype require more complex antihypertensive drug combinations.
• The Hp 2-2 phenotype is associated with a higher likelihood of atherosclerotic lesions in coronary and peripheral arteries.
• Hp 1-1 patients present with earlier diagnosis and lower complication rates, warranting closer monitoring for Hp 2-2 individuals.